Pacer Advisors
IART icon

Pacer Advisors’s Integra LifeSciences IART Stock Holding History

Pacer Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,135
Closed -$359K – 3768
2024
Q1 		$359K Sell
10,135
-88
-0.9% -$3.52K ﹤0.01% 1676
2023
Q4 		$445K Buy
10,223
+4,276
+72% +$168K ﹤0.01% 1563
2023
Q3 		$227K Sell
5,947
-6,553
-52% -$276K ﹤0.01% 1474
2023
Q2 		$514K Buy
+12,500
New +$602K ﹤0.01% 1467
2023
Q1 		– Sell
-13,920
Closed -$780K – 2282
2022
Q4 		$780K Buy
+13,920
New +$709K ﹤0.01% 976
2022
Q1 		– Sell
-7,381
Closed -$494K – 2405
2021
Q4 		$494K Buy
7,381
+90
+1% +$6.09K 0.01% 1579
2021
Q3 		$499K Sell
7,291
-180
-2% -$12.7K 0.01% 1145
2021
Q2 		$510K Sell
7,471
-90
-1% -$6.36K 0.01% 1128
2021
Q1 		$522K Sell
7,561
-289
-4% -$19.6K 0.01% 1040
2020
Q4 		$510K Sell
7,850
-9,142
-54% -$492K 0.01% 966
2020
Q3 		$802K Buy
+16,992
New +$808K 0.02% 806
2020
Q1 		– Sell
-24,306
Closed -$1.42M – 879
2019
Q4 		$1.42M Sell
24,306
-1,836
-7% -$109K 0.06% 427
2019
Q3 		$1.57M Sell
26,142
-2,007
-7% -$120K 0.04% 614
2019
Q2 		$1.57M Buy
+28,149
New +$1.45M 0.04% 604
2018
Q4 		– Sell
-25,068
Closed -$1.65M – 775
2018
Q3 		$1.65M Buy
25,068
+2,755
+12% +$171K 0.06% 413
2018
Q2 		$1.44M Buy
+22,313
New +$1.38M 0.07% 438
2017
Q4 		– Sell
-7,672
Closed -$387K – 1234
2017
Q3 		$387K Buy
7,672
+1,436
+23% +$73.8K 0.03% 785
2017
Q2 		$340K Buy
6,236
+376
+6% +$18K 0.03% 800
2017
Q1 		$247K Buy
5,860
+1,050
+22% +$44.9K 0.03% 838
2016
Q4 		$206K Buy
4,810
+114
+2% +$4.63K 0.03% 857
2016
Q3 		$194K Buy
+4,696
New +$197K 0.03% 832

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Pacer Advisors's IART Position: Q2 2024 in Review

Pacer Advisors sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 10,135 shares — an estimated $359K sold.

Pacer Advisors first reported a position in IART in Q3 2016 and held it in 21 quarters. The position peaked at $1.65M in Q3 2018. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

  • Pacer Advisors reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Pacer Advisors sold 10,135 Integra LifeSciences shares in Q2 2024, an estimated $359K.
  • Pacer Advisors first reported a position in Integra LifeSciences in Q3 2016 and held it in 21 quarters.
  • Pacer Advisors's Integra LifeSciences position peaked at $1.65M in Q3 2018.
  • 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on Pacer Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.